PedAM
Pediatric Disease Annotations & Medicines
| Disease | hypoglycemia |
| Phenotype | |type 1 diabetes |
| Sentences | 161 |
| PubMedID- 22074724 | Exclusion criteria included the following: type 1 diabetes, history of severe hypoglycemia within the past 2 years, known or suspected end-stage liver disease, cardiogenic shock at presentation, documented pregnancy, life expectancy of <90 days, anticipated poor adherence or loss to follow-up, and prior enrollment in this trial or current enrollment in another trial of ami. |
| PubMedID- 20873363 | Conclusions: insulin pump therapy has additional qualitative benefits beyond improvements in glycaemic control and reducing the risk of hypoglycaemia for people with type 1 diabetes. |
| PubMedID- 20132542 | We have no clear explanation why our results indicate a lower impact on hrqol of fear of hypoglycaemia in individuals with type 1 diabetes than those with type 2 diabetes. |
| PubMedID- 20811038 | Loss of the glucagon response to hypoglycemia in type 1 diabetes and advanced type 2 diabetes and less suppression of glucagon following a meal in diabetes may both be the result, at least in part, of β-cell failure (13). |
| PubMedID- 24130355 | Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the hypocompass trial. |
| PubMedID- 22784848 | Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. |
| PubMedID- 23630300 | All transplant recipients had long-standing c-peptide–negative type 1 diabetes complicated by hypoglycemia unawareness and frequent severe hypoglycemia events. |
| PubMedID- 22111165 | [recurrent hypoglycemia in a patient with type 1 diabetes. |
| PubMedID- 22071283 | The main goal of closed-loop therapy is to achieve good glycemic control while reducing the risk of hypoglycemia in people with type 1 diabetes. |
| PubMedID- 20723825 | hypoglycemia in type 1 diabetes mellitus. |
| PubMedID- 21737469 | We selected for inclusion only studies that were randomised controlled trials and that compared glycaemic control and hypoglycaemia in participants with type 1 diabetes treated by intensive insulin therapy (multiple daily insulin injections or continuous subcutaneous insulin infusion) where either real time continuous glucose monitoring or self monitoring of blood glucose was used throughout the study for at least two months. |